CN111624278A - Method for measuring caprolactam content in rearrangement - Google Patents

Method for measuring caprolactam content in rearrangement Download PDF

Info

Publication number
CN111624278A
CN111624278A CN202010435018.XA CN202010435018A CN111624278A CN 111624278 A CN111624278 A CN 111624278A CN 202010435018 A CN202010435018 A CN 202010435018A CN 111624278 A CN111624278 A CN 111624278A
Authority
CN
China
Prior art keywords
solution
caprolactam
standard
sample
mobile phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010435018.XA
Other languages
Chinese (zh)
Inventor
陈艳芬
王飞龙
吴道斌
杨立新
瞿亚平
刘期敏
吴望成
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujian Eversun Technology Co ltd
Original Assignee
Fujian Eversun Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujian Eversun Technology Co ltd filed Critical Fujian Eversun Technology Co ltd
Priority to CN202010435018.XA priority Critical patent/CN111624278A/en
Publication of CN111624278A publication Critical patent/CN111624278A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/86Signal analysis
    • G01N30/8624Detection of slopes or peaks; baseline correction
    • G01N30/8631Peaks
    • G01N30/8634Peak quality criteria

Landscapes

  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Quality & Reliability (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)

Abstract

The invention discloses a method for measuring caprolactam content in rearrangement, which comprises four steps of instrument preparation, standard solution preparation, sample solution preparation and sample injection analysis, and qualitatively and quantitatively analyzes the caprolactam content in discharged liquid by adopting a standard substance contrast method and an external standard method. The method has simple process and easy operation, eliminates human errors to the maximum extent, and has high accuracy of analysis results; optimizing the process and the device and improving the economic benefit of enterprises.

Description

Method for measuring caprolactam content in rearrangement
Technical Field
The invention belongs to the technical field of chemical substance analysis and detection, and particularly relates to a method for determining caprolactam content in heavy discharge liquid in caprolactam industry by high performance liquid chromatography.
Background
Caprolactam is an important petrochemical product for producing synthetic fibers and engineering plastics, and with the rapid development of economic construction in China, the demand of the market for caprolactam is rapidly increased, but the production capacity in China at present is far from meeting the demand of the market. The technical route for producing caprolactam at home and abroad mainly comprises a benzene method and a toluene method, and the production of caprolactam by the toluene method is a method for producing caprolactam by taking toluene as a raw material, which is developed by Italian St.A. (SNIA) company in 1960.
The prior method for producing caprolactam mostly uses benzene as a raw material, the material is subjected to oximation reaction, cyclohexanone oxime is subjected to Beckmann rearrangement reaction to form a caprolactam sulfuric acid solution, amide oil containing caprolactam, ammonium sulfate and byproducts is generated through neutralization, and the amide oil is separated, extracted and refined to obtain pure caprolactam and ammonium sulfate. The content of caprolactam in the heavy discharge liquid can be accurately determined, so that the acid-oxime ratio and the yield of the amide oil in the heavy discharge liquid can be effectively fed back. However, the sample is strongly acidic, contains a large amount of ammonium sulfate salts, and has a large amount of by-products and complex components. If the conventional gas chromatography is used for analysis, irreversible damage is easily caused to the instrument, and the separation effect is poor. The method uses a liquid chromatography analysis method to analyze caprolactam in the heavy discharge liquid, and obtains good effect.
Disclosure of Invention
The object of the present invention is to provide a method for determining the caprolactam content in rearrangement, which solves the problems mentioned in the background art.
In order to achieve the purpose, the invention provides the following technical scheme:
a method for determining caprolactam content in a rearrangement comprising the steps of:
1) preparing an instrument: a chromatographic column: c18 column, phi 4.6mm x 250 mm; mobile phase: performing low-pressure elution by combining a mobile phase A and a mobile phase B, wherein the mobile phase A is methanol, and the mobile phase B is pure water; flow rate: 1 mL/min; column temperature: 40 ℃; sample introduction amount: 20 mu L of the solution;
2) preparation of a standard solution: respectively weighing 0.2g, 0.4g, 0.6g, 0.8g and 1.3g of caprolactam, dissolving the caprolactam in pure water and diluting the caprolactam in a volumetric flask to obtain 1-5# standard solution;
3) preparing a sample solution: weighing 0.7g-1.4g of heavy liquid discharge sample in a beaker, dissolving, adjusting the pH to be less than 7 by using alkali liquor, transferring the sample into a volumetric flask, and carrying out constant volume to obtain solution C.
4) Sample injection analysis: under the condition of the high performance liquid chromatography, after the baseline of the instrument is stabilized, measuring standard solution and solution C, measuring the standard solution, continuously injecting a plurality of needle standard solutions until the area change of the solution of the two adjacent needle standard solutions is less than 1.5%, then measuring the solution C, injecting the two needle standard solutions after the area change of the solution C injected into the two needles is less than 1.5%, and injecting the solution C in the middle of the injection of the two needle standard solutions after the area change of the two needle standard solutions is less than 1.5%;
5) and (3) calculating: according to the peak-out retention time, qualitative determination of caprolactam in the solution C by using a standard substance contrast method; respectively recording the areas of the marking solution and the solution C in each needle in the step 4), and quantitatively calculating the content of caprolactam in the sample by using an external standard method.
As a further scheme of the invention: the volume ratio of the mobile phase A methanol to the mobile phase B pure water is 1: 4.
As a still further scheme of the invention: the mobile phase and sample were filtered through a corresponding 0.45um microporous membrane before entering the column.
Compared with the prior art, the invention has the beneficial effects that:
1. the method has simple process and easy operation, eliminates human errors to the maximum extent, and has high accuracy of analysis results;
2. optimizing the process and the device and improving the economic benefit of enterprises.
Drawings
FIG. 1 is an analytical spectrum of a standard solution, wherein 12.439min shows a peak of caprolactam;
FIG. 2 is an analytical spectrum of sample solution C, wherein 12.548min shows a peak of caprolactam.
FIG. 3 is a standard curve plot of the results of Table 1 for the standard samples.
Detailed Description
In the description of the present invention, it is to be understood that the terms "center", "longitudinal", "lateral", "up", "down", "front", "back", "left", "right", "vertical", "horizontal", "top", "bottom", "inner", "outer", and the like, indicate orientations or positional relationships based on those shown in the drawings, and are used only for convenience in describing the present invention and for simplicity in description, and do not indicate or imply that the referenced devices or elements must have a particular orientation, be constructed and operated in a particular orientation, and thus, are not to be construed as limiting the present invention. Furthermore, the terms "first", "second", etc. are used for descriptive purposes only and are not to be construed as indicating or implying relative importance or implicitly indicating the number of technical features indicated. Thus, a feature defined as "first," "second," etc. may explicitly or implicitly include one or more of that feature. In the description of the present invention, "a plurality" means two or more unless otherwise specified.
In the description of the present invention, it should be noted that, unless otherwise explicitly specified or limited, the terms "mounted," "connected," and "connected" are to be construed broadly, e.g., as meaning either a fixed connection, a removable connection, or an integral connection; can be mechanically or electrically connected; they may be connected directly or indirectly through intervening media, or they may be interconnected between two elements. The specific meaning of the above terms in the present invention can be understood by those of ordinary skill in the art through specific situations.
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
Referring to FIGS. 1-2, in one embodiment of the present invention, a method for determining caprolactam content in a rearrangement comprises the steps of: 1. preparing an instrument: a chromatographic column: c18 column, phi 4.6mm x 250 mm; mobile phase: performing low-pressure elution by combining a mobile phase A and a mobile phase B, wherein the mobile phase A is methanol, and the mobile phase B is pure water; flow rate: 1 mL/min; column temperature: 40 ℃; sample introduction amount: 20 mu L of the solution;
2. preparation of a standard solution: weighing 0.2g, 0.4g, 0.6g, 0.8g and 1.3g caprolactam respectively, dissolving with pure water and diluting in volumetric flask to obtain 1-5#A standard solution;
table 1:
Figure RE-GDA0002596226700000041
the results for the standard samples were plotted as a standard curve, as shown in FIG. 3.
3. Preparing a sample solution: weighing 0.7g-1.4g of heavy liquid discharge sample in a beaker, dissolving, adjusting the pH to be less than 7 by using alkali liquor, transferring the sample into a volumetric flask, and carrying out constant volume to obtain solution C.
In the preparation of the sample solution, the adjustment of the pH value to be less than 7 by using the alkali liquor means that the pH value of the sample is adjusted to be less than 7 by using the alkali liquor, and the pH value of the sample solution is strong acid after the sample is dissolved and cannot be directly measured, so that the sample can be injected only by adjusting the pH value of the sample solution to be close to 7 by using the alkali liquor.
4. Sample injection analysis: under the condition of the high performance liquid chromatography, after the baseline of the instrument is stabilized, measuring the standard solution and the solution C, measuring the standard solution, continuously injecting a plurality of needle standard solutions until the area change of the solution of the two adjacent needle standard solutions is less than 1.5%, then measuring the solution C, injecting the two needle standard solutions after the area change of the solution C injected into the two needles is less than 1.5%, and injecting the solution C in the middle of injecting the two needle standard solutions after the sample injection is finished.
Computing
The caprolactam content is:
Figure RE-GDA0002596226700000051
in the formula: a. the1: hexanoyl in the solution of the standard solutionAmine peak area;
A2: peak area of caprolactam in the sample solution;
m2: mass g of the heavy liquid;
ω1: the purity g/l of caprolactam standard sample;
v: sample dilution volume.
Wherein, the chromatogram of the standard solution is shown in figure 1, the chromatogram of the solution C is shown in figure 2, and the mass fraction of caprolactam in the sample is quantitatively calculated by an external standard method. The results are shown in table 2:
table 2:
Figure RE-GDA0002596226700000052
5. the precision of the method is as follows: are respectively paired with 4#The standard samples were tested in parallel l0 times with an average retention time of 12.4941min and a relative standard deviation of the retention time of 0.3988%, and the peak areas were recorded and the relative standard deviation of caprolactam determined was calculated to be 0.1199%. The results of the experiment are shown in table 3:
TABLE 3
Figure RE-GDA0002596226700000061
6. The accuracy of the method: the caprolactam standard recovery rate test is carried out on a rearrangement solution sample with a known concentration, the accuracy of the caprolactam standard recovery rate is expressed by the standard recovery rate, and the test result is shown in table 4:
TABLE 4
Figure RE-GDA0002596226700000062
Figure RE-GDA0002596226700000071
And (4) conclusion: the recovery rate of the added standard is 98-101%, which indicates that the accuracy of the method meets the analysis requirement.
Detection limit: under the optimal chromatographic condition of the method, the lowest detection limit of the method is calculated to be 0.01mg/L by using 3 times of limit noise.
It will be evident to those skilled in the art that the invention is not limited to the details of the foregoing illustrative embodiments, and that the present invention may be embodied in other specific forms without departing from the spirit or essential attributes thereof. The present embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein. Any reference sign in a claim should not be construed as limiting the claim concerned.
Furthermore, it should be understood that although the present description refers to embodiments, not every embodiment may contain only a single embodiment, and such description is for clarity only, and those skilled in the art should integrate the description, and the embodiments may be combined as appropriate to form other embodiments understood by those skilled in the art.

Claims (3)

1. A method for determining caprolactam content in rearrangement is characterized by comprising the following steps:
step 1:
preparing an instrument: a chromatographic column: c18 column, phi 4.6mm x 250 mm;
mobile phase: performing low-pressure elution by combining a mobile phase A and a mobile phase B, wherein the mobile phase A is methanol, and the mobile phase B is pure water; flow rate: 1 mL/min;
column temperature: 40 ℃; sample introduction amount: 20L;
step 2: preparation of a standard solution: respectively weighing 0.2g, 0.4g, 0.6g, 0.8g and 1.3g of caprolactam, dissolving the caprolactam in pure water and diluting the caprolactam in a volumetric flask to obtain 1-5# standard solution;
and step 3: preparing a sample solution: weighing 0.7g-1.4g of heavy-weight liquid discharge sample in a beaker, dissolving, adjusting the pH to be less than 7 by using alkali liquor, transferring the heavy-weight liquid discharge sample into a volumetric flask, and performing constant volume to obtain liquid C;
and 4, step 4: sample injection analysis: under the condition of the high performance liquid chromatography, after the baseline of the instrument is stabilized, measuring standard solution and solution C, measuring the standard solution, continuously injecting a plurality of needle standard solutions until the area change of the solution of the two adjacent needle standard solutions is less than 1.5%, then measuring the solution C, injecting the two needle standard solutions after the area change of the solution C injected into the two needles is less than 1.5%, and injecting the solution C in the middle of the injection of the two needle standard solutions after the area change of the two needle standard solutions is less than 1.5%;
and 5: and (3) calculating: according to the peak-out retention time, qualitative determination of caprolactam in the solution C by using a standard substance contrast method; and (4) respectively recording the areas of the marking solution and the solution C per needle in the step 4, and quantitatively calculating the content of caprolactam in the sample by using an external standard method.
2. The method of claim 1, wherein the volume ratio of the mobile phase A methanol to the mobile phase B pure water solution is 1: 4.
3. The method of claim 1, wherein the mobile phase and the sample are filtered through a 0.45um microporous membrane before entering the chromatographic column.
CN202010435018.XA 2020-05-21 2020-05-21 Method for measuring caprolactam content in rearrangement Pending CN111624278A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010435018.XA CN111624278A (en) 2020-05-21 2020-05-21 Method for measuring caprolactam content in rearrangement

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010435018.XA CN111624278A (en) 2020-05-21 2020-05-21 Method for measuring caprolactam content in rearrangement

Publications (1)

Publication Number Publication Date
CN111624278A true CN111624278A (en) 2020-09-04

Family

ID=72269940

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010435018.XA Pending CN111624278A (en) 2020-05-21 2020-05-21 Method for measuring caprolactam content in rearrangement

Country Status (1)

Country Link
CN (1) CN111624278A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10221325A (en) * 1997-02-04 1998-08-21 Mitsubishi Chem Corp Method of analyzing epsilon-caprolactam
US20020010329A1 (en) * 2000-06-27 2002-01-24 Yasumoto Shimazu Process for producing epsilon-caprolactam
CN102053120A (en) * 2009-10-30 2011-05-11 中国石油化工股份有限公司 Method for measuring content of cyclohexanone-oxime by liquid chromatography
WO2013099426A1 (en) * 2011-12-28 2013-07-04 住友化学株式会社 METHOD FOR PRODUCING ε-CAPROLACTAM
CN110895267A (en) * 2019-11-29 2020-03-20 福建永荣科技有限公司 Method for determining caprolactam content in ammonium sulfate by high performance liquid chromatography

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10221325A (en) * 1997-02-04 1998-08-21 Mitsubishi Chem Corp Method of analyzing epsilon-caprolactam
US20020010329A1 (en) * 2000-06-27 2002-01-24 Yasumoto Shimazu Process for producing epsilon-caprolactam
CN102053120A (en) * 2009-10-30 2011-05-11 中国石油化工股份有限公司 Method for measuring content of cyclohexanone-oxime by liquid chromatography
WO2013099426A1 (en) * 2011-12-28 2013-07-04 住友化学株式会社 METHOD FOR PRODUCING ε-CAPROLACTAM
CN110895267A (en) * 2019-11-29 2020-03-20 福建永荣科技有限公司 Method for determining caprolactam content in ammonium sulfate by high performance liquid chromatography

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
尹学军 等: "己内酰胺联产工艺中影响成品290nm处吸光度杂质的定性定量分析", 《石油化工》 *
赵晓君 等: "液相色谱法分析酸团中己内酰胺的含量", 《河北化工》 *

Similar Documents

Publication Publication Date Title
CN103454367B (en) A kind of method utilizing sulfate by ion chromatography monomethyl amine
CN111948306B (en) Method for determining genotoxic impurities in amlodipine besylate
CN111537657A (en) Method for detecting content of trace metal ions in high-purity thiourea by ion chromatography
CN111624278A (en) Method for measuring caprolactam content in rearrangement
CN103018368A (en) Method for determining N-methylamino ammate in production of acesulfame
CN106596795B (en) A method of ethylenediamine content in measurement lipoic acid injection
CN108627586A (en) A method of eight kinds of sweeteners and urethanes in white wine are quickly detected simultaneously using UPLC concatenations QDa
CN114577920B (en) Method for detecting fasudil hydrochloride and related substances thereof
CN114324642B (en) Method for determining dextromethorphan hydrobromide related substances
CN110895267A (en) Method for determining caprolactam content in ammonium sulfate by high performance liquid chromatography
CN115656360A (en) Quality control method of Voranolan fumarate intermediate
CN114778711A (en) Method for analyzing related substances of sulfadoxine
CN101025407A (en) Analytical method for determining micro moisture in cyclopropyl amine by gas phase chromatography
CN108872405A (en) A kind of HPLC analyzing detecting method of the lodoxamide tromethamine in relation to substance
CN107367558B (en) A kind of ion detection method of p-aminobenzoic acid
CN107941956B (en) High performance liquid chromatography analysis and detection method for tenofovir and enantiomer thereof
CN110618227B (en) Method for detecting dicyandiamide content in cyanamide solution by using HPLC method
CN110487937B (en) Identification method for white granulated sugar source producing area
CN114034792B (en) Liquid chromatographic analysis method for detecting chloroketone content
CN112782316B (en) Method for analyzing content of amitraz hydrochloride
CN118169297B (en) Analysis method for simultaneously detecting 1-propylphosphoric anhydride, propylphosphoric acid and propyldiethyl phosphate
CN114166968B (en) Method for rapidly determining content of glyphosate in glyphosate by liquid chromatography
CN112834643B (en) Method for measuring 2, 6-dihydroxy-4-methylpyridine and 2, 6-dihydroxy-3-cyano-4-methylpyridine
CN113030282B (en) Method for analyzing and detecting substances related to phthalimide potassium salt
CN118362662A (en) Method for detecting free melamine in melamine polyphosphate

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20200904

RJ01 Rejection of invention patent application after publication